Where is longevity headed? We've been hearing about 100+ biomarkers, peptides, and hormones—but is that what's really around the corner?

I just got back from three days at Eudemonia in Palm Beach, and I have thoughts. Today I'll share the topic I'm most excited about in longevity right now, plus the one I'd tell you not to spend money on yet.

Hang on - this is a big newsletter issue (and totally worth it!).

At Eudemonia, I had the chance to catch up with dozens of friends - movers and shakers in the longevity space - from all over the country!

The topic I'm most excited about is also the one I'm quite dubious of

I went to three booths and a happy hour all on regenerative therapies—specifically CellCoLabs, SHA Longevity, and Stemregen.

Quick primer: regenerative medicine uses your body's own repair mechanisms to heal or rejuvenate tissue.

The main players are stem cells (cells that can become different cell types) and exosomes (tiny vesicles that cells release to communicate with each other—think of them as cellular text messages carrying instructions).

Subscribe to keep reading

This content is free, but you must be subscribed to The Longevity Letter to continue reading.

Already a subscriber?Sign in.Not now

Reply

Avatar

or to participate